{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T14:27:04Z","timestamp":1785940024962,"version":"3.56.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>With the extensive use of aspirin in obstetrics and reproductive medicine, concerns of potentially related congenital anomalies have been raised in previous studies. However, there is a lack of evidence concerning the safety of application of aspirin during pregnancy in Chinese population, especially during the first trimester.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Patients and methods<\/jats:title>\n                <jats:p>We retrospectively included a total of 2,763 patients with 2,856 fetuses (2670 singleton births and 93 pairs of twins), among whom 1,684 took low dose aspirin (LDA) during pregnancy (the LDA group) and the other 1,079 were not exposed to LDA (the control group). The primary outcome was the rate of fetal congenital anomalies, and was compared between the LDA group and the control group. We also conducted logistic regression to examine the potential risk factors of congenital abnormalities.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The average daily dose of LDA taken was 67.6\u00a0mg. The rate of congenital anomalies was comparable between the two groups, suggesting low teratogenicity of LDA application during pregnancy (3.3% vs. 2.8%; <jats:italic>P<\/jats:italic>\u2009=\u20090.421). The duration of LDA exposure and the time of LDA exposure showed no association with congenital anomalies. A previous history of fetal congenital anomalies was associated with an increased risk of the recurrence of congenital anomalies in the siblings (adjusted OR\u2009=\u20093.00, 95% CI: 1.00\u20138.60; <jats:italic>P<\/jats:italic>\u2009=\u20090.041).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Exposure to LDA during pregnancy did not increase the risk of congenital anomalies in the fetus, suggesting that it was safe to apply LDA during pregnancy. A history of previous fetal abnormalities was found to be an independent risk factor of congenital anomalies. Our study suggests that LDA can be safely applied during pregnancy without increasing risks of congenital anomalies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-022-05142-8","type":"journal-article","created":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T11:03:05Z","timestamp":1667300585000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Effect of low dose aspirin application during pregnancy on fetal congenital anomalies"],"prefix":"10.1186","volume":"22","author":[{"given":"Si","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HongYang","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congcong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaohong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,1]]},"reference":[{"issue":"6","key":"5142_CR1","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","volume":"135","author":"Gestational Hypertension and Preeclampsia","year":"2020","unstructured":"Gestational Hypertension and Preeclampsia. ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020;135(6):e237\u201360.","journal-title":"Obstet Gynecol"},{"issue":"8","key":"5142_CR2","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1080\/14767058.2017.1404979","volume":"32","author":"C Lu","year":"2019","unstructured":"Lu C, Liu Y, Jiang HL. Aspirin or heparin or both in the treatment of recurrent spontaneous abortion in women with antiphospholipid antibody syndrome: a meta-analysis of randomized controlled trials. J Matern Fetal Neonatal Med. 2019;32(8):1299\u2013311.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"2","key":"5142_CR3","first-page":"315","volume":"35","author":"J Warkany","year":"1959","unstructured":"Warkany J, Takacs E. Experimental production of congenital malformations in rats by salicylate poisoning. Am J Pathol. 1959;35(2):315\u201331.","journal-title":"Am J Pathol"},{"issue":"(5 Pt 2 Suppl)","key":"5142_CR4","first-page":"930","volume":"62","author":"DG Corby","year":"1978","unstructured":"Corby DG. Aspirin in pregnancy: maternal and fetal effects. Pediatrics. 1978;62((5 Pt 2 Suppl)):930\u20137.","journal-title":"Pediatrics"},{"issue":"4","key":"5142_CR5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/aje\/kwm335","volume":"167","author":"ES Draper","year":"2008","unstructured":"Draper ES, Rankin J, Tonks AM, et al. Recreational drug use: a major risk factor for gastroschisis?. Am J Epidemiol. 2008;167(4):485\u201391.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"5142_CR6","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1586\/17512433.1.5.605","volume":"1","author":"HR Nakhai-Pour","year":"2008","unstructured":"Nakhai-Pour HR, B\u00e9rard A. Major malformations after first trimester exposure to aspirin and NSAIDs. Expert Rev Clin Pharmacol. 2008;1(5):605\u201316.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"6","key":"5142_CR7","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1067\/mob.2002.127376","volume":"187","author":"E Kozer","year":"2002","unstructured":"Kozer E, Nikfar S, Costei A, et al. Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol. 2002;187(6):1623\u201330.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"5142_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/humrep\/deq323","volume":"26","author":"DM Kristensen","year":"2011","unstructured":"Kristensen DM, Hass U, Lesne L, et al. Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat. Hum Reprod. 2011;26(1):235\u201344.","journal-title":"Hum Reprod"},{"issue":"4","key":"5142_CR9","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/0090-6980(83)90200-9","volume":"26","author":"K Momma","year":"1983","unstructured":"Momma K, Takeuchi H. Constriction of fetal ductus arteriosus by non-steroidal anti-inflammatory drugs. Prostaglandins. 1983;26(4):631\u201343.","journal-title":"Prostaglandins"},{"key":"5142_CR10","doi-asserted-by":"crossref","unstructured":"Duley L, Meher S, Hunter K E, et al. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev, 2019, 2019(10).","DOI":"10.1002\/14651858.CD004659.pub3"},{"issue":"10","key":"5142_CR11","doi-asserted-by":"publisher","first-page":"695","DOI":"10.7326\/M13-2844","volume":"160","author":"J T Henderson","year":"2014","unstructured":"Henderson J T, Whitlock E P, O\u2019connor E, et al. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia_ a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2014;160(10):695\u2013703.","journal-title":"Ann Intern Med"},{"issue":"4","key":"5142_CR12","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1097\/AOG.0000000000001301","volume":"127","author":"KA Ahrens","year":"2016","unstructured":"Ahrens KA, Silver RM, Mumford SL, et al. Complications and safety of preconception low-dose aspirin among women with prior pregnancy losses. Obstet Gynecol. 2016;127(4):689\u201398.","journal-title":"Obstet Gynecol"},{"key":"5142_CR13","doi-asserted-by":"publisher","unstructured":"Garza-Galvan ME, Ferrigno AS, Campos-Zamora M, et al. Low-dose aspirin use in the first trimester of pregnancy and odds of congenital anomalies: A meta-analysis of randomized controlled trials [published online ahead of print, 2022 Jul 10].\u00a0Int J Gynaecol Obstet. 2022; doi:https:\/\/doi.org\/10.1002\/ijgo.14334","DOI":"10.1002\/ijgo.14334"},{"issue":"6","key":"5142_CR14","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2217\/14622416.8.6.577","volume":"8","author":"Q Li","year":"2007","unstructured":"Li Q, Chen B-L, Ozdemir V, et al. Frequency of genetic polymorphisms of COX1, GPIIIa and P2Y1 in a Chinese population and association with attenuated response to aspirin. Pharmacogenomics. 2007;8(6):577\u201386.","journal-title":"Pharmacogenomics"},{"key":"5142_CR15","unstructured":"National Health and Family Planning Commission. Registration of birth defects in medical institutions, 2018."},{"key":"5142_CR16","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/(SICI)1096-9926(199904)59:4<182::AID-TERA2>3.0.CO;2-H","volume":"59","author":"RL Brent","year":"1999","unstructured":"Brent RL. Utilization of developmental basic science principles in the evaluation of reproductive risks from pre- and postconception environmental radiation exposures. Teratology. 1999;59:182\u2013204.","journal-title":"Teratology"},{"issue":"12","key":"5142_CR17","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.1073\/pnas.83.12.4346","volume":"83","author":"C Gupta","year":"1986","unstructured":"Gupta C, Goldman AS. The arachidonic acid cascade is involved in the masculinizing action of testosterone on embryonic external genitalia in mice. Proc Natl Acad Sci U S A. 1986;83(12):4346\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5142_CR18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1210\/endo-124-1-129","volume":"124","author":"C Gupta","year":"1989","unstructured":"Gupta C. The role of prostaglandins in masculine differentiation: modulation of prostaglandin levels in the differentiating genital tract of the fetal mouse. Endocrinology. 1989;124:129\u201333.","journal-title":"Endocrinology"},{"issue":"7974","key":"5142_CR19","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S0140-6736(76)93025-7","volume":"1","author":"D Slone","year":"1976","unstructured":"Slone D, Siskind V, Heinonen OP, et al. Aspirin and congenital malformations. Lancet. 1976;1(7974):1373\u20135.","journal-title":"Lancet"},{"issue":"3","key":"5142_CR20","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.ajog.2004.10.598","volume":"192","author":"B Norgard","year":"2005","unstructured":"Norgard B, Puho E, Czeizel AE, et al. Aspirin use during early pregnancy and the risk of congenital abnormalities: a population-based case-control study. Am J Obstet Gynecol. 2005;192(3):922\u20133.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"5142_CR21","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1002\/ajmg.a.38237","volume":"173","author":"K Brodwall","year":"2017","unstructured":"Brodwall K, Greve G, Leirgul E, et al. Recurrence of congenital heart defects among siblings-a nationwide study. Am J Med Genet A. 2017;173(6):1575\u201385.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"5142_CR22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12916-017-0789-5","volume":"15","author":"SV Glinianaia","year":"2017","unstructured":"Glinianaia SV, Tennant PW, Rankin J. Risk estimates of recurrent congenital anomalies in the UK: a population-based register study. BMC Med. 2017;15(1):20.","journal-title":"BMC Med"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-022-05142-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-022-05142-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-022-05142-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T23:03:29Z","timestamp":1667343809000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-022-05142-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["5142"],"URL":"https:\/\/doi.org\/10.1186\/s12884-022-05142-8","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,1]]},"assertion":[{"value":"11 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board of Ren Ji Hospital and conducted in accordance with the Declaration of Helsinki. Informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"802"}}